Quantitative high-throughput profiling of environmental chemicals and drugs that modulate farnesoid X receptor

Chia-Wen Hsu1, Jinghua Zhao1, Ruili Huang1

  • 1National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD.

Scientific Reports
|September 27, 2014
PubMed

Insights

Environmental chemicals and drugs were screened for their effects on the farnesoid X receptor (FXR), a key regulator of metabolic homeostasis. Several compound classes, including pyrethroids and microtubule inhibitors, were found to disrupt FXR activity, offering insights into potential toxicological mechanisms.

Area of Science:

  • Endocrinology and Toxicology
  • Molecular Biology
  • Pharmacology

Background:

  • The farnesoid X receptor (FXR) is a crucial nuclear receptor regulating bile acid, lipid, and glucose metabolism.
  • Understanding how xenobiotics interact with FXR is vital for assessing potential disruptions to metabolic homeostasis.

Purpose of the Study:

  • To screen a large collection of environmental chemicals and drugs for activity against the human FXR.
  • To identify structural classes of compounds that modulate FXR function and compare their activity profiles with other nuclear receptors.

Main Methods:

  • A cell-based human FXR β-lactamase (Bla) reporter gene assay was employed to screen the Tox21 10K compound library.
  • Structure-activity relationships were analyzed, and FXR-active compounds were compared against assays for androgen receptor, estrogen receptor α, PPARs, and VDR.

Main Results:

  • Several FXR-active structural classes were identified, including anthracyclines, benzimidazoles, dihydropyridines, pyrethroids, retinoic acids, and vinca alkaloids.
  • Microtubule inhibitors significantly reduced FXR reporter gene activity, while pyrethroids acted as specific FXR antagonists.
  • Anthracyclines exhibited non-specific activity across multiple tested assays.

Conclusions:

  • This screening provides a prioritized list of chemicals for further toxicological investigation.
  • The identified compounds and their structure-activity relationships offer insights into potential mechanisms of FXR signaling disruption by xenobiotics.

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
6.4K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
2.1K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
80
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
187